Farther Finance Advisors, LLC
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 1992825
SAN FRANCISCO, CA
Position in IMDX
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$3
New position
Shares Held
1
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Farther Finance Advisors, LLC holds $17,580,572 across 34 Diagnostics & Research names. IMDX ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
9,904 | $4,868,113 | |
| 2 | DHR |
Danaher Corp /De/
|
18,582 | $3,523,147 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
12,310 | $2,099,347 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
2,593 | $1,456,980 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
2,083 | $1,000,235 | |
| 6 | LH |
Labcorp Holdings Inc.
|
3,417 | $911,689 | |
| 7 | WAT |
Waters Corp /De/
|
1,973 | $587,559 | |
| 8 | A |
Agilent Technologies, Inc.
|
5,090 | $580,158 |
All Filings in IMDX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3 | 1 | Shares | Sole | 2026-04-07 | |
| No filing history on record for this holder in this stock. | ||||||